Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: David Lewis; David Rozema

Premium

Arrowhead Research announced that it has named David Lewis as its vice president of biology, and David Rozema as its vice president of chemistry.

Lewis and Rozema recently joined Arrowhead through the company's recent acquisition of Roche's Madison, Wis.-based RNA therapeutic operations (GSN 10/27/2011).

Lewis will oversee operations at the Madison facility and handle preclinical research and developments there. Rozema will supervise the development and synthesis of siRNA delivery vehicles.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.